NEUBASE THERAPEUTICS INC's ticker is NBSE and the CUSIP is 64132K102. A total of 61 filers reported holding NEUBASE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $3 | 0.0% | 17,777 | +0.1% | 0.00% | – |
| Q4 2022 | $3 | -99.9% | 17,767 | +38.3% | 0.00% | – |
| Q3 2022 | $5,000 | +150.0% | 12,851 | +558.7% | 0.00% | – |
| Q2 2022 | $2,000 | -91.3% | 1,951 | -83.8% | 0.00% | – |
| Q1 2022 | $23,000 | -58.9% | 12,072 | -39.5% | 0.00% | -100.0% |
| Q4 2021 | $56,000 | +1020.0% | 19,945 | +1300.6% | 0.00% | – |
| Q3 2021 | $5,000 | -80.0% | 1,424 | -73.2% | 0.00% | -100.0% |
| Q2 2021 | $25,000 | -62.1% | 5,306 | -40.5% | 0.00% | 0.0% |
| Q1 2021 | $66,000 | +69.2% | 8,924 | +59.3% | 0.00% | 0.0% |
| Q4 2020 | $39,000 | -68.0% | 5,603 | -65.0% | 0.00% | 0.0% |
| Q3 2020 | $122,000 | +281.2% | 16,025 | +342.1% | 0.00% | 0.0% |
| Q2 2020 | $32,000 | – | 3,625 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greenlight Capital | 2,027,027 | $14,169,000 | 0.85% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 103,500 | $723,000 | 0.55% |
| Sio Capital Management, LLC | 293,699 | $2,053,000 | 0.42% |
| GSA CAPITAL PARTNERS LLP | 121,389 | $849,000 | 0.14% |
| Frontier Wealth Management LLC | 145,000 | $1,014,000 | 0.08% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 311,000 | $2,174,000 | 0.06% |
| Oak Grove Capital LLC | 19,175 | $134,000 | 0.04% |
| PREMIER ASSET MANAGEMENT LLC | 14,977 | $105,000 | 0.02% |
| Trexquant Investment LP | 15,479 | $108,000 | 0.01% |
| PILLAR PACIFIC CAPITAL MANAGEMENT LLC | 19,800 | $138,000 | 0.01% |